# Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine

National Cancer Institute

## Source

National Cancer Institute. *Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine*. NCI Thesaurus. Code C48377.

A cell-based vaccine composed of autologous tumor cells fused with Epstein-Barr virus-transformed B-lymphoblastoid cells. Upon administration, this vaccine may stimulate a cytotoxic T cell response against tumor cells, resulting in tumor cell lysis. (NCI05)